Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasquale L Fedele

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2024
Chronic Lymphocytic Leukemia: Time to Care for the SurvivorsPasquale L Fedele, Stephen Opat
Leukemia & Lymphoma|January 29, 2025
Indolent lymphoma: addressing the needs of survivorsPasquale L Fedele, Stephen Opat
Pathology|August 28, 2014
Immunochromatographic antigen testing alone is sufficient to identify asymptomatic refugees at risk of severe malaria presenting to a single health service in VictoriaPasquale L Fedele, Michael Wheeler, Christopher Lemoh, et al.
Cardio-Oncology (London, England)|February 26, 2025
Survivorship clinic attendance improves completion but not timeliness of cardiac surveillance post anthracyclinesZac Forbes, Tegan Dunmall, Amanda Tey, et al.
Internal Medicine Journal|May 10, 2022
COVID-19 unmasks the critical role of primary healthcare providers in the timely diagnosis of multiple myelomaAdrian Chee, Michael S Y Low, Shahla Vilcassim, et al.
Annals of Hematology|January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphomaPasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
British Journal of Haematology|May 1, 2014
Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myelomaPasquale L Fedele, Kay-Weng Choy, James C G Doery, et al.
Transfusion|September 8, 2016
Profiling clinical platelet and plasma use to inform blood supply and contingency planning: PUPPY, the prospective utilization of platelets and plasma studyPasquale L Fedele, Mark N Polizzotto, George Grigoriadis, et al.
British Journal of Haematology|September 1, 2017
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myelomaAdrian Chee, Michael S Low, Shahla Vilcassim, et al.
Internal Medicine Journal|July 2, 2020
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experienceAditya Tedjaseputra, Michael Gilbertson, Michael Low, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2024
Chronic Lymphocytic Leukemia: Time to Care for the SurvivorsPasquale L Fedele, Stephen Opat
Leukemia & Lymphoma|January 29, 2025
Indolent lymphoma: addressing the needs of survivorsPasquale L Fedele, Stephen Opat
Pathology|August 28, 2014
Immunochromatographic antigen testing alone is sufficient to identify asymptomatic refugees at risk of severe malaria presenting to a single health service in VictoriaPasquale L Fedele, Michael Wheeler, Christopher Lemoh, et al.
Cardio-Oncology (London, England)|February 26, 2025
Survivorship clinic attendance improves completion but not timeliness of cardiac surveillance post anthracyclinesZac Forbes, Tegan Dunmall, Amanda Tey, et al.
Internal Medicine Journal|May 10, 2022
COVID-19 unmasks the critical role of primary healthcare providers in the timely diagnosis of multiple myelomaAdrian Chee, Michael S Y Low, Shahla Vilcassim, et al.
Annals of Hematology|January 24, 2016
Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphomaPasquale L Fedele, Gareth P Gregory, Michael Gilbertson, et al.
British Journal of Haematology|May 1, 2014
Inter-laboratory discordance of beta-2 microglobulin results: impact on the validity of the international staging system for multiple myelomaPasquale L Fedele, Kay-Weng Choy, James C G Doery, et al.
Transfusion|September 8, 2016
Profiling clinical platelet and plasma use to inform blood supply and contingency planning: PUPPY, the prospective utilization of platelets and plasma studyPasquale L Fedele, Mark N Polizzotto, George Grigoriadis, et al.
British Journal of Haematology|September 1, 2017
Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myelomaAdrian Chee, Michael S Low, Shahla Vilcassim, et al.
Internal Medicine Journal|July 2, 2020
Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experienceAditya Tedjaseputra, Michael Gilbertson, Michael Low, et al.
Pageof 2